Paranasal Sinus Diseases: Clinical Trials

3 trials for Paranasal Sinus Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3
Phase 31Unknown 1

Follow Paranasal Sinus Diseases: new trials by email Literature Review of Paranasal Sinus Diseases trials Research Report on Paranasal Sinus Diseases

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
611, Placebo - Sinusitis, Nasal Polyps
Phase 2UnknownSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.902023-06-302024-01-12
Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses
camrelizumab - Nasal Cavity Cancer, Paranasal Sinus Cancer
Phase 2UnknownSun Yat-sen University572021-04-162021-11-10
Investigating the Effect of Herbal Medicine Nasal Irrigation on Treatment of Chronic Rhinitis and Sinusitis
Taiwan Scientific" noninvasive blood pressure meter TS-0411, Meridian Energy Analysis Device(MEAD), bacteria culture - Nasal Disease
Phase 2 / Phase 3UnknownChang Gung Memorial Hospital2502019-12-312020-06-22

Narrower conditions

Sinusitis (2)  ·  Nasal Polyps (1)  ·  Nose Diseases (1)  ·  Paranasal Sinus Neoplasms (1)  ·  Polyps (1)  ·  Rhinitis (1)

Broader conditions

Otorhinolaryngologic Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Infections (2)  ·  Nose Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nose Neoplasms (1)  ·  Otorhinolaryngologic Neoplasms (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiratory Tract Neoplasms (1)

Interventions

camrelizumab (1)  ·  entacapone (1)

Sponsors

Chang Gung Memorial Hospital (1)  ·  Sun Yat-sen University (1)  ·  Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (1)

Countries

China (2)  ·  Taiwan (1)

Top investigators

Luo Zhang, MD (1)  ·  Pei-Rung Yang (1)  ·  Qinghong Zhou, BS (1)